Main Category: Stem Cell Research
Also Included In: Cancer / Oncology
Article Date: 23 Jul 2013 – 1:00 PDT
The incisor of the mouse, unlike any human tooth, grows continuously, and is an attractive focus for stem cell research, in Klein’s view. “There is a large population of stem cells, and the way the daughter cells of the stem cells are produced is easy to track – it’s as if they are on a conveyor belt,” he said. Early in life humans possess stem cells that similarly drive tooth development, but they become inactive after our adult teeth are fully formed during early childhood.
Please note: If no author information is provided, the source is cited instead.
Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
The study by Klein’s research team is published in the July issue of Nature Cell Biology, and was conducted on adult stem cells found in the large incisors of mice.
“Scientists have known that Bmi1 is a central control switch within the adult stem cells of many tissues, including the brain, blood, lung and mammary gland,” said Ophir Klein, MD, PhD, who directs the Craniofacial and Mesenchymal Biology (CMB) Program and serves as chair of the Division of Craniofacial Anomalies at UCSF. “Bmi1 also is a cancer-causing gene that becomes reactivated in cancer cells.”
University of California – San Francisco. “Research on cell-based therapy and cancer furthered by stem cell discovery.” Medical News Today. MediLexicon, Intl., 23 Jul. 2013. Web.
25 Jul. 2013. <http://www.medicalnewstoday.com/releases/263726.php>
In the current study, postdoctoral fellows Brian Biehs, PhD, and Jimmy Hu, PhD, determined that there is a group of adult stem cells at the base of the growing mouse incisor and that these stem cells possess active BMI1. They showed that BMI1 can suppress a set of genes called Hox genes that, when activated, trigger the development of specific cell types and body structures. In the mouse incisor, the researchers showed that activity of BMI1 in the stem cells maintains their stem cell fate and prevents inappropriate cell differentiation by suppressing the expression of Hox genes.
The hallmarks of all stem cells are that they are immature, they keep dividing to replenish their numbers almost indefinitely, and they generate new specialized cells to function in the tissues in which they reside, a process called cell differentiation.
Klein’s research group now has shown that BMI1 plays another role in ensuring that the process of development unfolds normally.
Pushed in one direction, the BMI1 switch enables normal stem cells to divide and renew their own numbers. Thrown in the other direction, it keeps cell proliferation in check. But now, Klein’s research team has shown that BMI1 also keeps this stock of stem cells from spinning off daughter cells that mature into the wrong type of specialized cell in the wrong place.
The research was funded by the National Institutes of Health and the California Institute for Regenerative Medicine.
The new discovery suggests that manipulating BMI1, along with other regulatory molecules, might one day be among the steps included in molecular recipes to turn specialized cell development on and off to create new cell-based treatments for tissues lost to injury, disease or aging, Klein said.
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Current ratings for:
Research on cell-based therapy and cancer furthered by stem cell discovery
The dual role of BMI1 also is intriguing to think about in pathological settings, such as cancer, Klein said. Growing evidence suggests that many cancers are driven by abnormally behaving adult stem cells or by cells that have abnormally acquired stem-cell-like properties. If these cancerous cells could be made to become specialized cells rather than stem cells when they divide, it might slow tumor growth, some cancer researchers believe. Inactivating BMI1 in cancer stem cells might be one strategy, Klein suggested.
stem cell research section for the latest news on this subject.
